Exactech Schedules Second Quarter 2017 Earnings Release and Conference Call

GAINESVILLE, Fla. (Jul. 13, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic materials for extremities, hip and knee will release its second quarter 2017 financial results on Thursday, July 27, 2017. A copy of the earnings release will be available at www.hawkassociates.com.

The company will hold a conference call with CEO David Petty and key members of the management team on Friday, July 28 at 10:00 a.m. EST. The call will cover Exactech’s second quarter 2017 results. Mr. Petty will open the conference call and a question-and-answer session will follow.

To participate in the call, dial 888-417-2254 any time after 9:50 a.m. EST on July 28. International and local callers should dial 719-325-4790. A live webcast of the call will be available at https://www.hawkassociates.com/profile/exac.cfm or https://public.viavid.com/index.php?id=125497.

This call will be archived for approximately 90 days.

About Exactech

Based in Gainesville, Fla., Exactech develops and markets orthopaedic implant devices, related surgical instruments and biologic materials and services to hospitals and physicians. The company manufactures many of its orthopaedic devices at its Gainesville facility. Exactech’s orthopaedic products are used in the restoration of bones and joints that have deteriorated as a result of injury or diseases such as arthritis. Exactech markets its products in the United States, in addition to more than 30 markets in Europe, Latin America, Asia and the Pacific. Additional information about Exactech can be found at https://aigrenoble.com.

A current investment profile on Exactech (Nasdaq: EXAC) is available online at https://www.hawkassociates.com/profile/exac.cfm. To receive future releases in e-mail alerts, sign up at https://www.hawkassociates.com/about/alert.

This release contains various forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which represent the company’s expectations or beliefs concerning future events of the company’s financial performance. These forward-looking statements are further qualified by important factors that could cause actual results to differ materially from those in the forward-looking statements. These factors include the effect of competitive pricing, the company’s dependence on the ability of third party manufacturers to produce components on a basis which is cost-effective to the company, market acceptance of the company’s products and the effects of government regulation. Results actually achieved may differ materially from expected results included in these statements.

Investor contacts

Jody Phillips
Executive Vice President of Finance & Chief Financial Officer

Julie Marshall or Frank Hawkins
Hawk Associates

Media contacts

Priscilla Bennett, Exactech
Vice President, Corporate & Marketing Communication